Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide After Hematopoietic Stem-cell Transplantation
NCT01735526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2014-09-23
Summary
Early after allogeneic hematopoietic stem-cell transplantation (allo-HSCT), reductions of absolute lung volume and diffusing capacity for carbon monoxide (DLCO) are frequently detected even in the absence of overt idiopathic pneumonia syndrome (IPS). It can be hypothesized that these changes might be due to an occult intersitial lung disease associated with infections, acute Graft-versus-Host Disease (aGvHD), myeloablative conditioning regimens or any combination of these. To test this hypothesis, we will simultaneously measure the lung diffusing capacity for nitric oxide (DLNO) and DLCO and estimate the changes of membrane diffusing capacity (DM) and pulmonary capillary volume (Vc) by the DLNO/DLCO ratio. As we hypothesize that GHVD should be intuitively absent amongst autologous HSCT (auto-HSCT) recipients, we will compare the changes in DLNO/DLCO ratio showed by the latter group with those of subjects undergoing allo-HSCT.
Conditions
Sponsors & Collaborators
-
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
lead OTHER
Principal Investigators
-
Giovanni Barisione, MD · IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Italy
Study Locations
More Related Trials
-
Pulmonary Complications of Hematopoietic Stem Cell Transplantation
NCT00837681 ·Status: COMPLETED
-
Impact of Pulmonary Follow-up After Stem Cell Graft
NCT03349372 ·Status: COMPLETED
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.
NCT02032381 ·Status: COMPLETED ·Phase: NA
-
Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation
NCT01275534 ·Status: COMPLETED
-
Pro-ADM vs PCT in Patients With Complications Post Hematopoietic Stem Cell Transplantation
NCT05523336 ·Status: UNKNOWN
-
Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion
NCT06639750 ·Status: NOT_YET_RECRUITING
-
Role of Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and Mortality After Allogeneic Stem Cell Transplantation
NCT05755633 ·Status: COMPLETED
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
NCT03000244 ·Status: RECRUITING
-
Immunomonitoring After Hematopoietic Stem Cell Transplantation
NCT04635397 ·Status: ACTIVE_NOT_RECRUITING
-
Study on Systemic and Airway Biomarkers in Haemopoietic Stem Cell Transplantation
NCT00956358 ·Status: COMPLETED
-
Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients
NCT07297303 ·Status: RECRUITING
-
Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03233659 ·Status: COMPLETED
-
Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant
NCT05766332 ·Status: COMPLETED
-
Acute Lung Injury After Allogeneic Transplantation - Diagnosis and Early Treatment
NCT00852605 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey
NCT04469985 ·Status: COMPLETED
-
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT00106925 ·Status: RECRUITING
-
Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients
NCT02623309 ·Status: COMPLETED ·Phase: PHASE3
-
Physical Deteriorations in Allo-HSCT.
NCT03606005 ·Status: COMPLETED
-
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)
NCT01675102 ·Status: COMPLETED
-
DNA Methylation in Allogeneic Hematopoietic Stem Cell Transplantation.
NCT03871296 ·Status: UNKNOWN
-
HLH Patients - a Retrospective Study
NCT05531721 ·Status: COMPLETED
-
Oral Hygiene Management of Hematologic Patients Undergoing Auto-transplantation
NCT06755333 ·Status: COMPLETED
-
ALLO-SCT in Elderly Patients With Hematological Disease
NCT04386928 ·Status: COMPLETED
-
Origin of CEC in Patients After Allo-HSCT
NCT04038827 ·Status: COMPLETED